期刊文献+

三维适形放疗在中枢神经系统白血病预防和治疗中的应用 被引量:2

Application of 3-D Comformal Radiation Therapy in Prophylaxis and Treatment in Central Nervous System Leukemia
下载PDF
导出
摘要 目的探讨三维适形放疗在中枢神经系统(CNS)白血病预防和治疗中的应用。方法回顾性分析28例急性淋巴细胞性白血病患者CNS预防或治疗方案,头颅三维适形放疗的方法、剂量以及疗效随访情况。结果7例CSF(-)者中枢预防放疗剂量12.6~18Gy/7~10Fx,诊断CNS白血病者放疗剂量18~23.4Gy/10~13Fx,脑实质占位性病变者全颅放疗21.6~24Gy后局部加量4~8Gy/2~4Fx。剂量偏差<10%,摆位误差范围3~5mm。随访6~55个月,所有患者存活,放疗中枢控制率82.1%。结论三维适形放疗可以准确地针对整个脑膜,不产生低剂量区,便于临床医生对放疗的副作用进行明确的剂量观察。头颅放疗控制和治疗发生最小副反应的剂量点在18Gy。 Objective To discuss the application of quality assurance in cranial radiation therapy and its development in central nervous system(CNS) leukemia. Methods A total of 28 patients were retrospectively analyzed of the prophylactic or therapeutic protocols of cranial radiation therapy, the methods and dosages of 3-D comformal radiation. Results Seven patients with CSF (-) were treated with prophylactic whole brain external beam irradiation 12.6-18 Gy/7-10 Fx. Those patients diagnosed with CNS leukemia were treated with 18-23.4 Gy/10-13 Fx. The patients with brain tumors in CNS were treated with additional 4-8 Gy/2-4 Fx focused on the tumor after whole brain external beam irradiation 21.6-24 Gy. The deviation of the radiation dosages was 〈10. The deviation of radiation area is about 3-5 mm. With 6-55 months follow-up, the control remission rate of CNS was 82. 1%. Conclusion The recommended dosage for CR is 18 Gy, which has the best quality assurance and least side-effects. 3-D comformal radiation is able to focus the beam onto the whole brain membranes, not yielding low-dosage area, and it is more convenient for the radiation therapist to supervise the radiation dosage.
出处 《上海第二医科大学学报》 CSCD 北大核心 2005年第8期844-846,共3页 Acta Universitatis Medicinalis Secondae Shanghai
关键词 三维适形放疗 白血病 中枢神经系统白血病 3-D conformal radiation therapy leukemia central nervous system leukemia
  • 相关文献

参考文献7

  • 1Burger B, Zimmermann M, Mann G, et al. Diagnostic cerebrospinal fluid examination in children with acute lymphoblastic leukemia: significance of low leukocyte counts with blasts or traumatic lumbar puncture[J]. J Clin Oncol, 2003,21(2): 179-181.
  • 2Grenzebach J, Schrappe M, Ludwig WD, et al. Favoralbe outcome for children and adolescents with T-cell lymphoblastic lymphoma with an intensive ALL-type therapy without local radiotherapy[J]. Ann Hematol, 2001, 80 (Suppl 3): S73-S76.
  • 3LeClerc JM, Billett AL, Gelber RD, et al. Treatment of childhood acute lymphoblastic leukemia: results of dana-farber all consortium protocol 87-01[J]. J Clin Oncol, 2002,20(1): 237-246.
  • 4Bhatia S, Sather HN, Pabustan OB, et al. Low incidence of second neoplasms among children diagnosed with acute lymphoblastic leukemia after 1983[J]. Blood, 2002,99(12): 4257-4264.
  • 5吴国华 陆冬青.儿童肿瘤的放射治疗[A].见:高解春 王耀平 主编.现代小儿肿瘤学[M].上海: 复旦大学出版社,2003.216-228.
  • 6Waber DP, Shapiro BL, Carpentieri SC, et al. Excellent therapeutic efficacy and minimal late neurotocicity in children treated with 18 grays of cranial radiation therapy for high-risk acute lymphoblastic leukemia[J]. Cancer, 2001, 92(1): 15-22.
  • 7Halperin EC, Laurie F, Fitzgerald TJ. Anevaluation of the relationship between the quality of prophylactic cranial radiotherapy in childhood acute leukemia and institutional experience: a quality assurance review center-pediatric oncology group study[J]. Int J Radiat Oncol Biol Phys, 2002, 53 (4):1001-1004.

同被引文献14

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部